Brown & Burk UK Limited
Registered name: BROWN & BURK UK LIMITED
Brown & Burk UK Limited made £36m revenue and £2.6m profit in the year to 31 Mar 2026. read from filing text
Brown & Burk UK Limited’s revenue grew 3% to £36m in the year to 31 Mar 2026, with £2.6m profit and 20 employees. The company is classified under “manufacture of pharmaceutical preparations” and is based in Hounslow; we hold 4 years of its filed accounts.
- Status
- Active
- Location
- Hounslow, London
- Age
- 26 yrs · since 2000
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The ultimate parent company and the largest company for which consolidated financial statements are”
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Mar 2023 | 31 Mar 2024 | 31 Mar 2025 | 31 Mar 2026 |
|---|---|---|---|---|
| Disclosure | Full P&Lread from filing text | Full P&Lread from filing text | Full P&Lread from filing text | Full P&Lread from filing text |
| Profit & loss | ||||
| Revenue (turnover) | £32.8m | £36m | £35m | £36m |
| Cost of sales | £23.3m | £25.6m | £27m | £28.9m |
| Gross profit | £9.6m | £10.4m | £8m | £7m |
| Operating profit | £7m | £7.1m | £4.7m | £3.4m |
| Profit before tax | £6.5m | £6.9m | £4.7m | £3.5m |
| Profit after tax | £5.3m | £5.3m | £3.6m | £2.6m |
| Profit (best available) | £5.3m | £5.3m | £3.6m | £2.6m |
| Staff costs | £1.4m | £1.6m | £1.6m | £1.7m |
| Employees (average) | 19 | 20 | 20 | 20 |
| Ratios | ||||
| Profit margin | 16.1% | 14.7% | 10.3% | 7.2% |
| Gross margin | 29.2% | 28.9% | 22.9% | 19.6% |
| Revenue per employee | £1.7m | £1.8m | £1.7m | £1.8m |
| Profit per employee | £278k | £264k | £180k | £130k |
| Growth (year on year) | ||||
| Revenue growth | — | ▲9.7% | ▼2.9% | ▲2.8% |
| Profit growth | — | ▲0% | ▼31.9% | ▼27.6% |
| Headcount growth | — | ▲5.3% | 0% | 0% |
| Balance sheet — indirect signals, not revenue | ||||
| Cash at bank | £6.4m | £3.5m | £4.6m | £5.5m |
| Net assets | £11.7m | £17m | £20.6m | £23.2m |
| Fixed assets | £8.5m | £8.5m | £8.3m | £8.3m |
| Current assets | £26.1m | £21.5m | £31.4m | £29.4m |
| Debtors | £6.9m | £5.8m | £8.4m | £7.8m |
| Deferred income | £2.6m | £2.5m | £2.3m | £1.6m |
| Source | FullAccounts · bulk data Jun 2024 | FullAccounts · bulk data Jun 2024 | FullAccounts · bulk data Nov 2025 | FullAccounts · bulk data Jun 2026 |
How the business works
- Profit margin
- 7.2%
- Profit ÷ revenue.
- Gross margin
- 19.6%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £1.8m
- Revenue ÷ average employees.
- Profit per employee
- £130k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 23.1%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- 4.6%
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 21.8%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▲13%
- Now £23.2m
- Cash at bank
- ▲20%
- Now £5.5m
- Headcount
- 0%
- Now 20
- Deferred income
- ▼27%
- Now £1.6m
- Fixed assets
- ▲0%
- Now £8.3m
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Similar profitable businesses
- Vertical Pharma Resources LimitedWest Molesey · Manufacture of pharmaceutical preparations
- Revenue
- £39.2m
- Profit
- £5.3m
- Staff
- 89
- Masters Pharmaceuticals LimitedElstree · Manufacture of pharmaceutical preparations
- Revenue
- £30.7m
- Profit
- £1.2m
- Staff
- 74
- Northumbria Pharma LtdSedgefield · Manufacture of pharmaceutical preparations
- Revenue
- £44.5m
- Profit
- £10.6k
- Staff
- 29
- Dermal Laboratories LimitedLoughton · Manufacture of pharmaceutical preparations
- Revenue
- £45.7m
- Profit
- £2.4m
- Staff
- 171
- Neon Healthcare LtdHertford · Manufacture of pharmaceutical preparations
- Revenue
- £51.2m
- Profit
- £1.7m
- Staff
- 21
- Morningside Healthcare LimitedNorthampton · Manufacture of pharmaceutical preparations
- Revenue
- £21.3m
- Profit
- £10.5m
- Staff
- 10
Sources
Latest figures from FullAccounts for the year to 31 Mar 2026 (profit £2.6m), from the Companies House accounts bulk data published Jun 2026. Spotted an error? Request a correction.
Updated from Companies House on 15 Oct 2026
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.